Thrombophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
161
|
43
|
0.700 |
None |
0.909 |
11 |
1
|
1991 |
2019 |
Thrombophilia due to Thrombomodulin Defect
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
3
|
0.700 |
None |
1.000 |
6 |
3
|
1995 |
2015 |
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6
|
disease |
|
Finding
|
1
|
7
|
0.600 |
None |
1.000 |
3 |
7
|
2009 |
2013 |
Atypical Hemolytic Uremic Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
56
|
42
|
0.570 |
limited |
1.000 |
7 |
2
|
2009 |
2018 |
Respiratory Distress Syndrome, Adult
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
434
|
60
|
0.550 |
None |
1.000 |
6 |
|
2003 |
2017 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.500 |
None |
1.000 |
2 |
|
2011 |
2014 |
Disseminated Intravascular Coagulation
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
117
|
3
|
0.400 |
None |
1.000 |
33 |
|
1994 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.400 |
None |
1.000 |
11 |
3
|
1997 |
2016 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.350 |
None |
1.000 |
7 |
|
1998 |
2018 |
Acute Promyelocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
651
|
21
|
0.340 |
None |
1.000 |
5 |
|
1994 |
2001 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.310 |
None |
1.000 |
3 |
|
2000 |
2003 |
Mechanical Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
408
|
4
|
0.310 |
None |
1.000 |
2 |
|
2016 |
2018 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.310 |
None |
1.000 |
2 |
|
2006 |
2010 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.300 |
None |
1.000 |
19 |
|
2007 |
2019 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
2 |
|
2000 |
2001 |
Pulmonary Thromboembolisms
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
33
|
6
|
0.300 |
None |
1.000 |
1 |
|
1995 |
1995 |
Tactile Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
114
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperalgesia, Secondary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
88
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperalgesia, Primary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Purpura, Thrombotic Thrombocytopenic
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
80
|
13
|
0.300 |
None |
1.000 |
1 |
|
1995 |
1995 |